Abstract
Mucosal healing has been a focus of attention as an emerging ideal treatment goal of Crohn’s disease. Endoscopy is the gold standard for evaluating mucosal lesion. Objective precise monitoring, especially for the small bowel, is important for stratifying the treatment strategy. Some limitations and issues for definition of mucosal healing, accessibility of stricture or adhesion, feasible endoscopic score still remain. It is important in clinical practice to identify the appropriate time for intensifying the CD treatment for small ulcerative lesion endoscopically. There are characters for each imaging modality, for instance assessment of intestinal tract wall and extrawall information. The combination with other complementary imaging modalities or biomarkers is useful in optimizing the CD treatment strategy. An appropriate accelerated step-up treatment strategy combined with stratified precise monitoring of the SB should provide optimal prognosis in patients with CD. Endoscopic prediction of long-term prognosis or efficacy of treatment is an important subject for investigation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hall B, Holleran G, Chin JL, et al. A prospective 52 week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy. J Crohns Colitis. 2014;8:1601–9.
Mandel MD, Miheller P, Müllner K, et al. Have biologics changed the natural history of Crohn’s disease? Dig Dis. 2014;32:351–9.
Pariente B, Cosnes J, Danese S, et al. Development of the Crohn’s disease digestive damage score, the Lémann score. Inflamm Bowel Dis. 2011;17:1415–22.
Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619–35.
D'Incà R, Caccaro R. Measuring disease activity in Crohn's disease: what is currently available to the clinician. Clin Exp Gastroenterol. 2014;20:151–61.
Beppu T, Ono Y, Matsui T, et al. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn’s disease. Dig Endosc. 2015;27:73–81.
Frøslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412–22.
Bouguen G, Levesque BG, Pola S, et al. Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2014;12:978–85.
Morimoto K, Watanabe K, Noguchi A, et al. Clinical impact of ultrathin colonoscopy for Crohn’s disease patients with strictures. J Gastroenterol Hepatol. 2015;30(Suppl 1):66–70.
Yamagami H, Watanabe K, Kamata N, et al. Small bowel endoscopy in inflammatory bowel disease. Clin Endocrinol. 2013;46:321–6.
Takenaka K, Ohtsuka K, Kitazume Y, et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with Crohn’s disease. Gastroenterology. 2014;147:334–42.
Annese V, Daperno M, Rutter MD, et al. European evidence-based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018.
Bryant RV, Winer S, Travis SP, et al. Systematic review: histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative. J Crohns Colitis. 2014;8:1582–97.
Cohen SA, Ephrath H, Lewis JD, et al. Pediatric capsule endoscopy: review of the small bowel and patency capsules. J Pediatr Gastroenterol Nutr. 2012:54409–13.
Herrerias JM, Leighton JA, Costamagna G. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008;67:902–9.
Maconi G, Bolzoni E, Giussani A, et al. Accuracy and cost of diagnostic strategies for patients with suspected Crohn’s disease. J Crohns Colitis. 2014;8:1684–92.
Atreya R, Neumann H, Neufert C, et al. In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn’s disease. Nat Med. 2014;20:313–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Japan
About this chapter
Cite this chapter
Watanabe, K. et al. (2018). The Efficacies and Issues for Endoscopic Assessment of Mucosal Healing in Patients with Crohn’s Disease. In: Hibi, T., Hisamatsu, T., Kobayashi, T. (eds) Advances in Endoscopy in Inflammatory Bowel Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56018-0_19
Download citation
DOI: https://doi.org/10.1007/978-4-431-56018-0_19
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56016-6
Online ISBN: 978-4-431-56018-0
eBook Packages: MedicineMedicine (R0)